Women Veterans with epilepsy and psychiatric comorbidities: a call to action

Abstract: Over 3 million adults live with active epilepsy in the United States,1 and it is estimated that 1 in 26 people will develop it in their lifetime. This is a compelling …

Psychiatric comorbidities in women Veterans with epilepsy

Abstract: Background: Women Veterans with epilepsy (WVE) may have unique psychiatric comorbidities that affect presentation, treatment, and outcomes. This large, nationally …

First unprovoked seizures among soldiers recruited to the Israeli Defense Forces during 10 consecutive years: A population-based study

Abstract: Objective: The management of patients after a first unprovoked seizure (FUS) can benefit from stratification of the average 50% risk for further seizures. We …

The role of deployment history on the association between epilepsy and traumatic brain injury in post-9/11 era U.S. Veterans

Abstract: BACKGROUND AND OBJECTIVES: Traumatic brain injury (TBI) is a well-established epilepsy risk factor and is common among service members. Deployment related TBI, where …

Prescribing trends of antiseizure drugs in women Veterans with epilepsy

Abstract: OBJECTIVE: Antiseizure medications (ASMs) are frequently used for other indications, such as migraine, pain syndromes, and psychiatric disorders. Possible teratogenic …

Patterns of psychotropic drug use in veterans with epilepsy: Do drug interactions matter?

Abstract: Patients with epilepsy are likely to suffer from psychiatric comorbidities, including depression and anxiety. They often require treatment with multiple psychotropic …